Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Jan;34(1):80-9.
doi: 10.1016/j.jsat.2006.11.012. Epub 2007 Jun 15.

Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence

Affiliations
Randomized Controlled Trial

Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence

Frances R Levin et al. J Subst Abuse Treat. 2008 Jan.

Abstract

Co-occurring psychiatric disorders have been associated with poor prognosis among substance-dependent patients, but few studies have examined this association among patients with cocaine dependence (CD). We compared baseline characteristics and treatment outcome between cocaine-dependent patients with major depressive disorder (MDD; n = 66), those with attention-deficit/hyperactivity disorder (ADHD; n = 53), and those with CD without comorbid disorders (CD alone; n = 48) who had been randomized to the placebo arms of clinical trials with venlafaxine, methylphenidate, and gabapentin, respectively. The three groups differed significantly in racial makeup, with more Caucasians and Hispanics among patients with MDD and those with ADHD but more African Americans among those with CD alone. The groups did not differ significantly in treatment retention, with retention rates ranging from 42% to 47%; neither did they differ in the rates of achieving 2 consecutive weeks of urinalysis-confirmed abstinence, with rates ranging from 40% to 50%. Using logistic regression for repeated measures with general estimating equations, modeling the likelihood of a cocaine-positive week over time in treatment, we found the diagnostic group to interact with the baseline level of cocaine use and time. Among cocaine-dependent patients who achieved abstinence at baseline, those with MDD and those with ADHD had better outcome over time as compared with patients with CD alone. However, among patients with cocaine-positive urine specimens at baseline, those with MDD and those with ADHD were associated with poor outcome as compared with patients with CD alone. The findings suggest that diagnosis and treatment of co-occurring disorders such as depression and ADHD may be important components of treatment planning for CD and that the baseline level of cocaine use should be included as a covariate in studies evaluating the impact of such treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 1a. Logistic regression model of cocaine use over time for patients with cocaine negative urines during the baseline week. Groups have cocaine dependence plus major depression (CD +MDD), cocaine dependence plus ADHD (CD + ADHD), and cocaine dependence alone (CD) Figure 1b. Logistic regression model of cocaine use over time for patients with cocaine positive urines during the baseline week. Groups have cocaine dependence plus major depression (CD +MDD), cocaine dependence plus ADHD (CD + ADHD), and cocaine dependence alone (CD).
Figure 1
Figure 1
Figure 1a. Logistic regression model of cocaine use over time for patients with cocaine negative urines during the baseline week. Groups have cocaine dependence plus major depression (CD +MDD), cocaine dependence plus ADHD (CD + ADHD), and cocaine dependence alone (CD) Figure 1b. Logistic regression model of cocaine use over time for patients with cocaine positive urines during the baseline week. Groups have cocaine dependence plus major depression (CD +MDD), cocaine dependence plus ADHD (CD + ADHD), and cocaine dependence alone (CD).

References

    1. Agosti V, Stewart JW, Quitkin FM. Life Satisfaction and Psychosocial Functioning in Chronic Depression: Effect of Acute Treatment with Antidepressants. J Affect Disord. 1991;23(1):35–41. - PubMed
    1. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive Deficits Predict Low Treatment Retention in Cocaine Dependent Patients. Drug Alcohol Depend. 2006;81(3):313–22. - PubMed
    1. Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV. A Randomized Placebo-Controlled Trial of Gabapentin for Cocaine Dependence. Drug Alcohol Depend. 2006;81(3):267–74. - PubMed
    1. Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Vosburg SK, Nunes EV. Utility of Lead-in Period in Cocaine Dependence Pharmacotherapy Trials. Drug Alcohol Depend. 2005;77(1):7–11. - PubMed
    1. Brown RA, Monti PM, Myers MG, Martin RA, Rivinus T, Dubreuil ME, Rohsenow DJ. Depression among Cocaine Abusers in Treatment: Relation to Cocaine and Alcohol Use and Treatment Outcome. Am J Psychiatry. 1998;155(2):220–5. - PubMed

Publication types

MeSH terms